Bartram Richard 4
4 · Esperion Therapeutics, Inc. · Filed Mar 16, 2022
Insider Transaction Report
Form 4
Bartram Richard
Chief Financial Officer
Transactions
- Award
Common Stock
2022-03-14+37,000→ 82,751 total
Holdings
- 159,000
Stock Option (right to buy
Exercise: $4.74Exp: 2032-03-14→ Common Stock (159,000 underlying)
Footnotes (2)
- [F1]The awards will vest quarterly over four years beginning on March 15, 2022.
- [F2]Consists of 82,751 shares of common stock held, including 1,899 shares acquired in Esperion's Employee Stock Purchase Plan.